From: The Scientific Innovation Team on Molecular Cancer Research and Clinical Transformation and Application Release time: 2016-04-29 11:50:40 Browsing times: 49 Font Size: 14

　　The Scientific Innovation Team of Molecular Cancer Research and Clinical Transformation and Application of our hospital was listed as the Tangshan Science and Technology Research and Development Project (2015, the Third batch) by the Tangshan Health and Family Planning Commission and the Tangshan Science and Technology Board. The team members are backbones from cancer related clinical departments (Department of Chemotherapy, Breast Surgery, etc) and Central Laboratory. The core team members are Hu Wanning, Sun Guogui, Han Xiaochen, Zhang Jinghua, Liu Weidong, Yang Junquan, Li Yufeng, etc. The construction period is from December 2015 to December 2018.

　　The team aims to clarify the expression profiles and risk stratification of circular RNA (circRNA) in breast cancer, gastric cancer and lung cancer, in order to find novel makers for early diagnoses of cancers and novel therapeutic targets for blocking recurrence, invasion and metastasis of cancers.

The Scientific Innovation Team of Cancer Molecular Research and Clinical Transformation and Application of Tangshan People's Hospital